(Q35651376)

9 August 2017

title

Pharmacokinetics and pharmacodynamics of ciprofloxacin in cystic fibrosis patients (English)

1 reference

9 August 2017

0 references

1 reference

1 reference

LeBel M

1

1 reference

9 August 2017

Bergeron MG

2

1 reference

9 August 2017

Vallée F

3

1 reference

9 August 2017

Fiset C

4

1 reference

9 August 2017

Chassé G

5

1 reference

9 August 2017

Bigonesse P

6

1 reference

9 August 2017

Rivard G

7

1 reference

9 August 2017

language of work or name

English

0 references

publication date

1 August 1986

1 reference

9 August 2017

number of pages

7

1 reference

Antimicrobial Agents and Chemotherapy

inferred from page(s)

published in

1 reference

9 August 2017

volume

30

1 reference

9 August 2017

issue

2

1 reference

9 August 2017

page(s)

260-266

1 reference

Theophylline disposition in cystic fibrosis

9 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180531

In vitro activity of ciprofloxacin, a new carboxyquinoline antimicrobial agent

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180531

Pharmacokinetics of intravenously administered ciprofloxacin

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180531

A multicenter comparison of related pharmacologic features of cephalexin and dicloxacillin given for two months to young children with cystic fibrosis.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180531

Management of acute pulmonary exacerbations in cystic fibrosis: a critical appraisal

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180531

Pharmacokinetics of ciprofloxacin after oral and parenteral administration

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180531

Tissue penetration of ciprofloxacin after single and multiple doses

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180531

Pharmacokinetics of three oral formulations of ciprofloxacin

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180531

Noncompartmental determination of the steady-state volume of distribution for any mode of administration.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180531

Activity of ciprofloxacin (BAYo 9867) against Pseudomonas aeruginosa and ampicillin-resistant Enterobacteriaceae

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180531

Cloxacillin absorption and disposition in cystic fibrosis

25 September 2018

1 reference

12 December 2020

Long-term study of one hundred five patients with cystic fibrosis; studies made over a five- to fourteen-year period

1 reference

12 December 2020

Single-dose pharmacokinetics of oral ciprofloxacin in patients with cystic fibrosis

1 reference

12 December 2020

Enhanced renal excretion of dicloxacillin in patients with cystic fibrosis

1 reference

12 December 2020

Intravenous aminophylline in patients with cystic fibrosis. Pharmacokinetics and effect on pulmonary function

1 reference

12 December 2020

Dosing implications of rapid elimination of trimethoprim-sulfamethoxazole in patients with cystic fibrosis

1 reference

12 December 2020

Noncompartmental determination of the steady-state volume of distribution during multiple dosing

1 reference

12 December 2020

Ceftazidime disposition in acute and stable cystic fibrosis

1 reference

12 December 2020

Cephalexin pharmacokinetics in patients with cystic fibrosis

1 reference

12 December 2020

Problems and pitfalls in estimating average pharmacokinetic parameters

1 reference

12 December 2020

Pharmacokinetics of ciprofloxacin after oral and intravenous administration in healthy volunteers

1 reference

12 December 2020

Dose- and sex-independent disposition of ciprofloxacin

1 reference

12 December 2020

Determination of ciprofloxacin in biological samples by reversed-phase high performance liquid chromatography

1 reference

12 December 2020

Identifiers

DOI

10.1128/AAC.30.2.260

1 reference

9 August 2017

1 reference

9 August 2017

1 reference